5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Suraksha Diagnostic Ltd.

•
surakshanet.comBSE: 544293NSE: SURAKSHA
Market Cap₹ 1,688 Cr.
Current Price
High / Low₹ 349 / 224
Stock P/E45.9
Book Value₹ 50
Price to Book4.78
Dividend Yield0.15 %
ROCE25.6 %
ROE14.7 %
Face Value₹ 2

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company has delivered good profit growth of 39.4% CAGR over last 5 years
  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 25.0%
  • Operating margins have improved to 31.8% from 25.8%
  • Latest quarter profit grew 27.7% YoY, showing strong momentum
  • Company has delivered good sales growth of 16.5% CAGR over last 5 years

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • Promoter holding has decreased over last 2 years: -13.9pp
  • Equity base is being diluted - shares outstanding up 51.0%
  • Though reporting repeated profits, the company pays out little dividend (7.6%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcareHospital & Healthcare Services
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.APOLLOHOSP8850.0060.90127249.420.23610.4038.417043.5020.5621.7315.70
2.MAXHEALTH1037.2069.29100951.740.19322.964.872366.1716.7014.9725.29
3.MANIPALHOS716.15105.5794200.740.002434.30—30906.30—13.9323.83
4.FORTIS887.3063.9366987.440.11272.802.262545.0317.4614.0721.28
5.ASTERDM762.95208.6966504.250.3929.28-68.701310.6821.6011.2619.53
6.MEDANTA1447.5569.9838920.530.03157.25-1.091304.0526.5019.3821.99
7.NH1867.3546.7638161.310.24207.275.372683.6378.0516.2017.43
8.KIMS768.85158.0632292.200.0037.40-56.001179.5035.3311.5119.03
9.LALPATHLAB1909.4059.1432049.051.071705.001172.397977.001090.9529.5631.03
10.AGARWALEYE507.00108.3316073.230.00550.201345.616140.201159.7316.1427.75
11.VIJAYA1502.3082.5315473.350.1353.1037.61230.9822.8330.2842.66
12.SURAKSHA324.0547.151687.680.1512.8440.0087.6520.7424.9734.73
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
605155606659647076767984
393635394240444652525569
Operating Profit211620212418202424232415
OPM %35.07%30.26%35.98%34.92%35.75%30.89%30.91%33.92%31.43%30.68%30.31%17.42%
110111111112
Interest222222233344
Depreciation8889999910101111
Profit before Tax1171011148101313111116
Tax %24.04%24.27%29.85%25.76%24.19%24.47%20.22%24.92%25.54%25.80%36.46%22.39%
Net Profit957811681098713
1.620.921.281.562.021.221.541.891.801.561.292.42

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
124132151157140223190219249301314
101105116123117175145147166205229
Operating Profit2327353423484572839686
OPM %18.29%20.49%23.11%21.65%16.18%21.54%23.94%32.93%33.42%31.77%27.22%
11121243445
Interest543222101091313
Depreciation1112121316153233354041
Profit before Tax8122121633833444750
Tax %42.90%28.98%18.39%27.61%-0.96%28.45%8.67%25.44%23.76%27.86%26.87%
Net Profit481715624724333437
EPS0.000.000.00178.0076.00278.491.35353.396.426.54—
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%7.64%—

COMPOUNDED SALES GROWTH

10 Years:
12%
5 Years:
17%
3 Years:
17%

COMPOUNDED PROFIT GROWTH

10 Years:
20%
5 Years:
39%
3 Years:
68%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
4%

RETURN ON EQUITY

10 Years:
12%
5 Years:
14%
3 Years:
15%
Last Year:
15%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Sep 15

₹ 0.25

Rs.0.5000 per share(25%)Final Dividend

2026

Aug 25

₹ 0.25

Rs.0.5000 per share(25%)Final Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
777777771010
717996111118141148172204238
31122081619867574134
Trade Payables8121113131414141419
31352834171927333148
Total Liabilities148145162173171201282302333450
9996127128119119195211215284
Capital Work in Progress46000121535
181025600136
4465466788
000000091525
Cash & Bank68344355531625
16212430387123207167
Total Assets148145162173171201282302333450

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
24234238254752616380
Cash from Investing-38-2-30-20-28-44-22-35-39-51
Cash from Financing12-17-7-1031-24-26-24-28
-32-11-1-0-10-11

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Mar 2022Mar 2023Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
62.9662.9648.7848.7848.8848.9849.0049.1049.10
0.000.0015.3914.4613.9513.7313.4613.4613.47
0.000.0020.4322.0522.3721.9822.5723.1423.22
Government0.000.000.000.000.000.000.000.000.00
37.0437.0415.3914.7014.8015.3114.9814.3114.21

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-31
Copy of Newspaper Publication

2026-08-31 - Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication published today, i.e. on Monday, 31 August, 2026 with respect to the Notice of the 21st Annual General Meeting of the Company scheduled to be held on Tuesday, 22 September, 2026 and e-voting information.

2026-08-27
General Updates

2026-08-27 - Pursuant to Regulation 36(1)(b) of the SEBI Listing Regulations, a letter to those Members whose e-mail addresses are not registered with the Company/Registrar and Share Transfer Agent (RTA), i.e. KFin Technologies Limited/Depository Participants (DPs)/Depositories is being dispatched by the Company.

2026-08-27
Shareholders meeting

2026-08-27 - Notice of 21st Annual General Meeting to be held on September 22, 2026.

2026-08-25
Copy of Newspaper Publication

2026-08-25 - Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-25
Copy of Newspaper Publication

2026-08-25 - Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-17
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-17 - Suraksha Diagnostic Limited has informed the Exchange about Transcript

2026-08-17
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-17 - Suraksha Diagnostic Limited has informed the Exchange about Transcript

2026-08-13
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-13 - Suraksha Diagnostic Limited has informed the Exchange about Link of Recording

2026-08-13
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-13 - Suraksha Diagnostic Limited has informed the Exchange about Link of Recording

News

Recent coverage and analyst commentary for SURAKSHA

Loading news…

🤖

AI Stock Analyst

Suraksha Diagnostic Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login